Webinar on SOPs for Clinical Trials: Regulatory Requirements

MessageThis Webinar is over
Date Jun 2, 2016
Time 10:00 am
Cost $150.00
Online
Overview:  
Since the year 2000 there has been an increasing trend of registered clinical studies from approximately 4,000 in 2000 to 160,000 in 2014. In 2014 Forbes Magazine reported that the FDA had approved 44 drugs the highest in 18 years.
As innovation and new technological approaches are applied to the discovery of novel molecules, the number of studies will continue to increase to meet the areas of unmet medical needs and especially rare diseases. Clinical Trial.gov currently list 193,510 studies in 50 states and in 190 countries.

Why should you Attend:
In clinical research, Standard Operating Procedures (SOPs) assist in defining the clinical groups standard practices and daily processes conducted to assure execution of research task in accordance with institutional, state and federal guidelines. 
Since the 1970s the regulations for conducting clinical trials has been under the directions of the Food and Drug Administration’s Good Clinical Practice (GCPs) and human subject protection (HSP) Guidelines. The International Conference on Harmonization (ICH) defines a SOP as “Detailed, written instructions to achieve uniformity of the performance of a specific function”. In simple terms a SOP is a written process and a way for the clinical site(s) to perform a task the same way each time it is completed. 
Areas Covered in the Session:
ICH guidelines and Good Clinical Practice (GCP)
Standard Operating Procedures (SOPs)
Benefits of SOPs
Writing SOPs
Highlight Different SOP Topics
Regulatory Requirement of SOPs
Importance of SOPs in Data Management
Study Participant Recruitment Plans

Who Will Benefit:
Healthcare Providers in Clinical Research
New Clinical Research Coordinators (1-2 years)
New Principal Investigators
Administrative Managers in charge of Clinical Research
Regulatory Compliance Associates and Managers
Medical Writers
Nursing and/or Clinical Monitoring Staff
Marketing Team Members

Speaker Profile: 
Harold Thibodeaux is a medical research scientist with in vivo pharmacological experiences in both academia and biopharmaceutical industry. During his prestigious career the focus of Mr. Thibodeaux’s research efforts has been on the efficacy of cardiovascular drugs most notably Hypertension, Myocardial Infarction, Focal Ischemia (Stroke), Beyond Advair Pulmonary Research and topical antibiotics. Optimal therapeutic benefits were the goal in all of these projects but cardiovascular safety to provide safer medicines to patients was a priority. Mr. Thibodeaux transitioned into the pharmaceutical industry when he joined the Cardiovascular Department of Genentech in 1990, as a technical lead with the Second Generation TPA Project Team. Mr. Thibodeaux is a graduate from the College of Charleston with a Bachelor of Science Degree in biology and is a member of The Safety Pharmacology Society. 

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
http://www.compliance4all.com/
Event Link : http://bit.ly/Regulatory_Requirements
LinkedIn Like us
Twitter Follow us
Facebook Like us

 


comments powered by Disqus
Create your own event
Turn your passion into a business.
Join our mailing list